Literature DB >> 10487961

Intraocular pressure-lowering activity of phenolic antioxidants in normotensive rabbits.

L C Hodges1, C E Kearse, K Green.   

Abstract

PURPOSE: The purpose of this study was to determine the intraocular pressure (IOP)-lowering activity of phenolic antioxidants injected intravenously into normotensive rabbits. Antioxidants belonging to the following classes were tested: cinnamic acids; flavonols; flavanols; anthocyanidins; isoflavones; and tannic acid.
METHODS: Test compounds were dissolved in either water or oil/saline as vehicle and injected intravenously into normotensive rabbits. IOP was monitored hourly after injection and expressed as a percent relative to preinjection values. Controls were conducted using vehicle alone. IOP from each eye was averaged to provide one value per rabbit. Dose-response data beginning at 0.01 mg-2 mg doses were collected for compounds shown to be active at 1 mg.
RESULTS: Epigallocatechin, epigallocatechin gallate and myricetin lowered IOP below control levels at doses of 1 mg. Tannic acid was the most active, lowering IOP more than 30% at doses of 200 microg.
CONCLUSION: Only phenolic antioxidants containing a pyrogallol B-ring system and nonaromatic C-ring (epigallocatechin, epigallocatechin gallate and myricetin) or possible galloyl glucosides as found in tannic acid were active in lowering IOP, with tannic acid being the most active. Other antioxidants were not active in this system suggesting a more specific structural requirement for interacting with appropriate ocular systems. The protein or proteoglycan-binding properties of these molecules may also be important in this activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10487961     DOI: 10.1076/ceyr.19.3.234.5320

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  6 in total

Review 1.  Potential of the bioflavonoids in the prevention/treatment of ocular disorders.

Authors:  Soumyajit Majumdar; Ramesh Srirangam
Journal:  J Pharm Pharmacol       Date:  2010-08       Impact factor: 3.765

2.  Caffeine consumption and the risk of primary open-angle glaucoma: a prospective cohort study.

Authors:  Jae Hee Kang; Walter C Willett; Bernard A Rosner; Susan E Hankinson; Louis R Pasquale
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-02-08       Impact factor: 4.799

Review 3.  Myricetin: A Dietary Molecule with Diverse Biological Activities.

Authors:  Deepak Kumar Semwal; Ruchi Badoni Semwal; Sandra Combrinck; Alvaro Viljoen
Journal:  Nutrients       Date:  2016-02-16       Impact factor: 5.717

4.  Effect of Myricetin on Primary Open-angle Glaucoma.

Authors:  Qing Yang; Ying Li; Lin Luo
Journal:  Transl Neurosci       Date:  2018-11-12       Impact factor: 1.757

5.  New micelle myricetin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment.

Authors:  Fengyuan Sun; Zhou Zheng; Jie Lan; Xuefei Li; Mengshuang Li; Kaichao Song; Xianggen Wu
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

6.  Efficacy of Hyperbaric Oxygen Therapy on Central Corneal Thickness, Intraocular Pressure, and Nerve Fiber Layer in Patients with Type 2 Diabetes: A Prospective Cohort Study.

Authors:  Havva Kaldırım; Kürsat Atalay; Banu Ceylan; Serpil Yazgan
Journal:  Korean J Ophthalmol       Date:  2020-12-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.